Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Last trade$7.54
Day change+$0.07 (+0.94%)
Day range$6.60 – $7.65
Volume3,095,294
Market cap$1.56B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.56B
Price / earnings
54.06×
Price / book
5.64×
Price / sales
0.32×
EV / sales
0.24×
EV / EBITDA
110.28×
Profitability
Earnings per share
$0.14
Return on assets
2.23%
Return on equity
10.44%
Dividend yield
0%
Liquidity and leverage
Debt / equity
1.17×
Current ratio
1.71×
Quick ratio
1.71×
Cash ratio
1.06×
Cash flow
Price / cash flow
14.47×
Price / free cash flow
20.29×
Free cash flow
$77.04M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for ALHC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$1.35B
$1.33B
$1.23B
$975.8M
$983.68M
$1.01B
$918.04M
$669.61M
Cost of revenue
$1.22B
$1.15B
$1.09B
$889.49M
$868.02M
$881.74M
$820.9M
$614.9M
Gross profit
$130.65M
$171.95M
$135.85M
$86.31M
$115.66M
$124.46M
$97.14M
$54.72M
Selling, general and administrative
$136.37M
$131M
$121.14M
$125.76M
$110.02M
$103.8M
$103.83M
$102.13M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$144.48M
$138.86M
$128.98M
$133.59M
$117.99M
$110.8M
$111.43M
$108.89M
Operating income
-$13.83M
$33.09M
$6.87M
-$47.29M
-$2.33M
$13.66M
-$14.28M
-$54.18M
Interest expense
-$4.28M
-$4.28M
-$4.06M
-$3.95M
-$3.95M
-$3.95M
-$3.95M
-$5.49M
Income before taxes
-$8.07M
$37.83M
$11.44M
-$14.23M
$3.73M
$18.88M
-$9.33M
-$31.06M
Income taxes
-$22K
$1.27M
$25K
-$3.23M
$2K
$3.22M
$21K
$7K
Net income
-$8.05M
$36.56M
$11.42M
-$11.01M
$3.73M
$15.65M
-$9.35M
-$31.06M
Net income attributable to common shareholders
-$8.05M
$36.56M
$11.42M
-$11.01M
$3.73M
$15.67M
-$9.11M
-$31.09M
EBITDA
-$5.71M
$40.95M
$14.73M
-$39.45M
$5.65M
$20.7M
-$6.66M
-$47.37M
Basic earnings per share
-$0.04
$0.18
$0.06
-$0.05
$0.02
$0.08
-$0.05
-$0.16
Diluted earnings per share
-$0.04
$0.17
$0.05
-$0.06
$0.02
$0.07
-$0.05
-$0.16
Recent news
Company coverage with links to the original publishers.
Law firm Glancy Prongay Wolke & Rotter LLP is investigating Alignment Healthcare, Inc. for potential securities fraud following a whistleblower lawsuit alleging the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The disclosure on July 8, 2026 caused the stock to drop 16.7% to $20.03 per share. Investors who suffered losses may be eligible to pursue claims.
The Law Offices of Howard G. Smith is investigating Alignment Healthcare, Inc. following a July 8, 2026 whistleblower lawsuit alleging financial manipulation. A former executive claimed the company misclassified $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The stock declined 16.7% ($4.02 per share) to $20.03 on the disclosure. The firm is examining potential claims for investors who suffered losses.
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare, Inc. for potential securities fraud following a 16.7% stock price decline on July 8, 2026. A former executive filed a whistleblower lawsuit alleging the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. Investors who suffered losses may be eligible to pursue claims.
Alignment Healthcare (ALHC) reported a quarterly loss of $0.04 per share, matching consensus estimates, with revenues of $1.36 billion exceeding expectations by 3.63%. However, the stock has declined 58.6% year-to-date, significantly underperforming the S&P 500's 13.1% gain. The company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends, with the Medical Services industry ranking in the bottom 40% of sectors.
Alignment Healthcare reported Q3 2026 revenue of $1.36 billion, up 36.7% year-over-year and beating consensus estimates by 3.63%. However, EPS came in at -$0.04, matching expectations but showing no improvement from the prior year. Key metrics showed a medical benefits ratio of 89.5% (slightly above estimates) and health plan membership growth to 301,200. The stock carries a Zacks Rank #4 (Sell) rating and has underperformed the broader market.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.